EastPharma Ltd. reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2012. For the quarter, revenue cost of revenue was EUR 212,072,291 against EUR 226,211,561 a year ago. Operating profit was EUR 32,795,243 against EUR 37,558,649 a year ago. Profit before taxation was EUR 20,946,153 against EUR 17,678,757 a year ago. Profit for the period attributable to equity share holders of the parent company was EUR 17,185,470 or EUR 0.0009 per share against EUR 7,198,213 or EUR 0.0004 per share a year ago.

For the six months, revenue cost of revenue was EUR 112,408,669 against EUR 110,293,940 a year ago. Operating profit was EUR 20,418,597 against EUR 4,352,069 a year ago. Profit before taxation was EUR 12,608,416 against loss before taxation of EUR 8,823,608 a year ago. Profit for the period attributable to equity share holders of the parent company was EUR 9,892,234 or EUR 0.0005 per share against loss for the period EUR 7,385,524 or EUR 0.0004 per share a year ago. Net cash provided by operating activities was EUR 6,830,330 against net cash used in operating activities EUR 25,574,953 a year ago. Purchase of property, plant and equipment was EUR 16,335,286 against EUR 10,882,779 a year ago.